Jingying Xu

发表

Comparative study on the acute pulmonary toxicity induced by 3 and 20nm TiO(2) primary particles in mice.

Yongjun Li, Jing-ying Xu, Qingnuan Li, 2007, Environmental toxicology and pharmacology.

Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.

T. Pietsch, Jingying Xu, A. Waha, 2009, Neoplasia.

Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages.

M. Iruela-Arispe, Lily Wu, Jingying Xu, 2012, Blood.

c-Abl mediates endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 and by disruption of actin.

A. Erdreich-Epstein, Jingying Xu, X. Ren, 2010, Blood.

c-Abl mediates endothelial apoptosis induced by inhibition of integrins v 3 and v 5 and by disruption of actin

A. Erdreich-Epstein, Jingying Xu, X. Ren, 2010 .

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.

Christine E Brown, Wen-Chung Chang, S. Riddell, 2016, Blood.

The Chromatin-Modifying Protein HMGA2 Promotes Atypical Teratoid/Rhabdoid Cell Tumorigenicity

B. Weissman, C. Eberhart, A. Erdreich-Epstein, 2015, Journal of neuropathology and experimental neurology.

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

J. Biegel, B. Weissman, C. Eberhart, 2014, Oncotarget.

Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.

Xiaodong Sun, Lixia Lu, Jing-ying Xu, 2020, Life sciences.

SUMOylation of GMFB regulates the stability and function of GMFB in RPE cells under oxidative stress and inflammation

Juan Wang, Furong Gao, Jieping Zhang, 2021, bioRxiv.

Metabolism of Orthotopic Mouse Brain Tumor Models

S. Blüml, J. Finlay, A. Erdreich-Epstein, 2009, Molecular imaging.

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

T. Graeber, A. Ribas, Stephen Mok, 2014, Cancer research.

Microenvironment and Immunology CSF 1 R Signaling Blockade Stanches Tumor-In fi ltrating Myeloid Cells and Improves the Ef fi cacy of Radiotherapy in Prostate Cancer

Stephen Mok, G. Bollag, J. David, 2013 .

Fullerenol protects retinal pigment epithelial cells from oxidative stress-induced premature senescence via activating SIRT1.

Ling Chen, P. Li, F. Wang, 2014, Investigative ophthalmology & visual science.

Pediatric Brain Tumor Cell Lines

S. Asgharzadeh, A. Erdreich-Epstein, Jingying Xu, 2015, Journal of cellular biochemistry.

Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126.

P. Laird, M. Campan, W. Ye, 2017, Oncotarget.

PID1 (NYGGF4), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas

David T. W. Jones, F. Gilles, M. Kool, 2013, Clinical Cancer Research.

c-Abl Is an Upstream Regulator of Acid Sphingomyelinase in Apoptosis Induced by Inhibition of Integrins αvβ3 and αvβ5

A. Erdreich-Epstein, Jingying Xu, Min H. Kang, 2012, PloS one.

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.

Christopher R. Cabanski, Lacey J. Kitch, Vanessa M. Hubbard-Lucey, 2021, The Lancet. Oncology.

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.

Stephen Mok, G. Bollag, J. David, 2013, Cancer research.

Novel cell lines established from pediatric brain tumors

J. Biegel, R. Moats, A. Erdreich-Epstein, 2012, Journal of Neuro-Oncology.

CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.

S. Schokrpur, L. Lacombe, Jiaoti Huang, 2015, Cancer research.

Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma

Hao Chen, Juan Wang, Furong Gao, 2022, Frontiers in Oncology.

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Christopher R. Cabanski, Vanessa M. Hubbard-Lucey, E. Wherry, 2022, Nature Medicine.

Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

Jonathan H. Esensten, J. Bluestone, V. Nguyen, 2021, Frontiers in Immunology.

Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia

F. Couch, E. Fung, F. Gilles, 2015, Front. Oncol..

Wnt pathway in atypical teratoid rhabdoid tumors.

D. Catchpoole, A. Erdreich-Epstein, Jingying Xu, 2015, Neuro-oncology.

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

T. Graeber, A. Ribas, Stephen Mok, 2014, Cancer research.

NR4A1 inhibits the epithelial–mesenchymal transition of hepatic stellate cells: Involvement of TGF-β–Smad2/3/4–ZEB signaling

Jingying Xu, Jingying Xu, Yue Shi, 2022, Open life sciences.

Surface morphology and action mechanism of macrophage immunostimulating activity of Rosa Setate x Rosa Rugosa polysaccharide WSRP-1b

Qifeng Han, Y. Zhang, Wenqing Zhang, 2023, Carbohydrate Polymer Technologies and Applications.

Metagenomic Next-Generation Sequencing for the Diagnosis of Suspected Opportunistic Infections in People Living with HIV

Zongxing Yang, Jingying Xu, Jianhua Yu, 2022, Infection and drug resistance.

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

J. Biegel, B. Weissman, C. Eberhart, 2014, Oncotarget.